Atlas Trials

HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2

Clinical trial NCT05787418 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT05787418
Sponsor
Huahui Health
Status
ENROLLING_BY_INVITATION
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2023-03-31
Primary completion
2025-12-31
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.